Altisource Residential Corporat (RESI) 21.19 $RESI 3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Altisource Residential Corporat (RESI) 21.19 $RESI

3 Hold-Rated Dividend Stocks: AINV, RESI, TWO
at The Street - Tue Mar 17, 10:30AM CDT
These 3 dividend stocks are rated a Hold by TheStreet
AINV: 7.57 (+0.14), TWO: 10.90 (+0.13), RESI: 21.19 (+0.13)

Get 37.35% Leverage In 5 REIT Highest Yield, Lowest Price, March 13 Stocks
Fredrik Arnold - at Seeking Alpha - Tue Mar 17, 9:00AM CDT

GOV: 23.29 (+0.51), RSO: 4.74 (-0.03), SIR: 25.57 (+0.73), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), IRT: 9.50 (+0.03), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), JMI: 8.42 (-0.12), CORR: 7.03 (+0.25)

REITs: Yield To 18.48%, Upside To 26.9%, Gains To 40.6% As Of 3/13/15
Fredrik Arnold - at Seeking Alpha - Tue Mar 17, 8:39AM CDT

RSO: 4.74 (-0.03), SIR: 25.57 (+0.73), AHH: 10.93 (-0.01), IRT: 9.50 (+0.03), AHT: 10.16 (+0.27), GOV: 23.29 (+0.51), STAG: 24.62 (+0.56), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), MNR: 11.32 (+0.26), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), CORR: 7.03 (+0.25), JMI: 8.42 (-0.12)

REITs Stocks Technical Review -- CYS Investments, Newcastle Investment, Altisource Residential, Camden Property Trust, and AvalonBay Communities
PR Newswire - Mon Mar 16, 8:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AVB: 179.83 (+5.04), CPT: 80.61 (+2.75), NCT: 4.85 (+0.06), RESI: 21.19 (+0.13), CYS: 8.97 (+0.02)

10%-37% Upsides From Ten Russell 2000/1000 Combo Index Dogs?
Fredrik Arnold - at Seeking Alpha - Mon Mar 16, 2:44AM CDT

PMT: 21.39 (+0.08), RSO: 4.74 (-0.03), MTGE: 18.19 (-0.24), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), SFL: 14.63 (+0.17), RAS: 6.65 (-0.09), CORR: 7.03 (+0.25), AMTG: 16.34 (+0.38), NRF: 18.89 (+0.32)

10 Rousing Russell 2000 Dividend Dogs Dole 10% To 37% March Upsides
Fredrik Arnold - at Seeking Alpha - Fri Mar 13, 4:42PM CDT

PMT: 21.39 (+0.08), RSO: 4.74 (-0.03), MITT: 18.82 (+0.29), MTGE: 18.19 (-0.24), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), CYS: 8.97 (+0.02), SFL: 14.63 (+0.17), AI: 25.19 (+0.25), WMC: 15.53 (+0.21), DX: 8.49 (+0.18), RAS: 6.65 (-0.09), NYMT: 8.11 (+0.10), CORR: 7.03 (+0.25), AMTG: 16.34 (+0.38)

Altisource Residential declares $0.08 dividend
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 3:59PM CDT

RESI: 21.19 (+0.13)

Altisource Residential Corporation Announces Special Cash Dividend
GlobeNewswire - Thu Mar 12, 3:54PM CDT
Altisource Residential Corporation ("Residential" or the "Company" (NYSE:RESI) today announced that its Board of Directors has declared a special cash dividend of $0.08 per share of common stock, or an aggregate of $4.3 million based on shares outstanding. This dividend is intended to complete the distribution of 100% of Residential's taxable income for the year ended December 31, 2014. The Company will pay this dividend on March 30, 2015 to all stockholders of record as of the close of business on March 23, 2015.
RESI: 21.19 (+0.13)

3 Stocks Spiking on Unusual Volume
at The Street - Mon Mar 09, 1:06PM CDT
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
GIMO: 21.46 (-0.24), RESI: 21.19 (+0.13), ULTA: 152.02 (-0.27)

Altisource Asset Management Corporation Announces Rescheduling of Conference Call for Fourth Quarter and Full Year 2014 Results
GlobeNewswire - Mon Mar 09, 7:18AM CDT
Altisource Asset Management Corporation ("AAMC" (NYSE MKT:AAMC) announced today that it is rescheduling its earnings conference call for the fourth quarter and full year of 2014. The call was originally scheduled for today, March 9, 2015 at 11:30 a.m. Eastern.
RESI: 21.19 (+0.13), AAMC: 206.00 (+1.78)

Altisource Residential Corporation Announces Rescheduling of Conference Call for Fourth Quarter and Full Year 2014 Results
GlobeNewswire - Mon Mar 09, 7:17AM CDT
Altisource Residential Corporation ("Residential" (NYSE:RESI) announced today that it is rescheduling its earnings conference call for the fourth quarter and full year of 2014. The call was originally scheduled for today, March 9, 2015 at 10:00 a.m. Eastern.
RESI: 21.19 (+0.13), AAMC: 206.00 (+1.78)

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
AWR: 41.40 (+0.45), RESI: 21.19 (+0.13), BRK.B: 145.53 (+0.65), ACLS: 2.47 (-0.07), AVGO: 133.29 (+1.25)

Beware The REITs Of March: 18.42% Yield; 19.55% Upside; 25.98% Net Gain
Fredrik Arnold - at Seeking Alpha - Wed Mar 04, 2:38AM CST

RSO: 4.74 (-0.03), SIR: 25.57 (+0.73), IRT: 9.50 (+0.03), AHT: 10.16 (+0.27), HPT: 33.97 (+1.04), WSR: 16.32 (+0.41), SNH: 22.98 (+0.70), STAG: 24.62 (+0.56), GOV: 23.29 (+0.51), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), MNR: 11.32 (+0.26), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), ORC: 13.68 (+0.08), ADC: 34.17 (+0.67), CORR: 7.03 (+0.25), JMI: 8.42 (-0.12)

5 Foremost Financial Dividend Dogs Deal 16% To 20% Early March Upsides
Fredrik Arnold - at Seeking Alpha - Tue Mar 03, 8:54AM CST

RSO: 4.74 (-0.03), MTGE: 18.19 (-0.24), CYS: 8.97 (+0.02), TICC: 6.84 (+0.09), CMO: 12.27 (+0.20), NYMT: 8.11 (+0.10), RAS: 6.65 (-0.09), APO: 22.24 (+0.05), TCRD: 11.95 (+0.04), BDC: 92.13 (+1.46), FSC: 7.18 (+0.09), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), WMC: 15.53 (+0.21), KCAP: 7.00 (+0.07), PSEC: 8.56 (+0.05)

Altisource Residential beats by $0.11, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 7:09AM CST

RESI: 21.19 (+0.13)

Altisource Residential Corporation Reports Fourth Quarter and Full Year 2014 Results
GlobeNewswire - Mon Mar 02, 7:00AM CST
Altisource Residential Corporation ("Residential" or the "Company" (NYSE:RESI) announced today financial and operating results for the fourth quarter and full year of 2014. Net income for the fourth quarter of 2014 totaled $41.5 million, or $0.72 per diluted share, compared to net income of $21.6 million, or $0.50 per diluted share, for the fourth quarter of 2013. Net income for the year ended December 31, 2014 totaled $188.9 million, or $3.34 per diluted share, compared to net income of $39.6 million, or $1.61 per diluted share, for the year ended December 31, 2013.
RESI: 21.19 (+0.13)

JLL Raises Credit Facility to $2B, Extends Date Till 2020 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 11:00AM CST
In order to bolster its operating flexibility, JLL has made amendments to its existing credit facility.
JLL: 169.56 (+5.10), RESI: 21.19 (+0.13), ALEX: 41.26 (+1.11)

St. Joe Incurs Loss in Q4, Revenues Fall Year over Year - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 8:39AM CST
The St. Joe Company (JOE) reported fourth-quarter 2014 net loss of $11.1 million, or 12 cents per share of loss against net income of $0.5 million, or zero cents per share in the year-ago quarter.
BRP: 24.24 (+0.01), JOE: 18.01 (+0.43), RESI: 21.19 (+0.13), ALEX: 41.26 (+1.11)

CBRE to Sell Malls in France, Belgium for $1.4B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 3:24PM CST
CBRE (CBG) intends to divest 10 shopping malls in France and Belgium, per a report by the French daily newspaper, Le Figaro.
CBG: 36.79 (+1.05), RESI: 21.19 (+0.13), ALEX: 41.26 (+1.11)

3 Hold-Rated Dividend Stocks: GMLP, RESI, APO
at The Street - Thu Feb 19, 9:30AM CST
These 3 dividend stocks are rated a Hold by TheStreet
APO: 22.24 (+0.05), GMLP: 26.94 (+0.60), RESI: 21.19 (+0.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading

Top 5 Most Recently Viewed Articles

Abionic's Innovative IVD CAPSULE PSP Receives FDA Clearance

Updated Category News Views 96

Abionic achieved FDA 510(k) clearance for its IVD CAPSULE PSP back in 2024, marking a pivotal point in medical diagnostics. Desks were buzzing as traders recognized the potential of this test to accelerate sepsis detection—an urgent health crisis impacting around 50 million patients globally each year. Sepsis: A Global Health Emergency Sepsis isn't just another medical...

Continue Reading
Revolutionizing Patient Care with Avextra's Breakthrough Capsules

Updated Category News Views 135

Avextra's Innovative Approach to Patient-Centric Therapy With evidence-based clinical development and new pharmaceutical formulations, Avextra aims to enhance patient experience and adherence. In the ever-evolving realm of medical therapies, the question arises: How can treatments involving Cannabis-based medicines (CbM) be both effective and user-friendly? Traditionally,...

Continue Reading
LIBERTY Dental Plan Provides Significant Support for Hurricane Aid

Updated Category News Views 33

LIBERTY Dental Plan's Generosity Shines in Crisis LIBERTY Dental Plan of Florida, Inc. (LIBERTY), a prominent dental benefits administrator, is stepping up to aid communities affected by devastating hurricanes. With a timely donation of $10,000, LIBERTY is supporting hurricane relief efforts aimed at restoring normalcy in impacted areas. A Helping Hand for Florida...

Continue Reading
Discover the Growth of $1000 in Lloyds Banking Group

Updated Category News Views 218

The Transformation of a $1000 Investment in Lloyds Banking Group Lloyds Banking Group (NYSE: LYG) has shown impressive growth over the last five years, outpacing the market with an annualized return of 20.92%. With a current market capitalization of $82.67 billion, it’s a notable player in the financial sector. How Much Would Your Investment Be Worth? For an investor...

Continue Reading
Understanding KKR's Growth: A Decade of Investment Success

Updated Category News Views 652

Investing in KKR: A 10-Year Journey Investing wisely is all about understanding the market and making informed choices. Over the last decade, KKR has emerged as a prominent player, significantly outperforming the market with an annualized return of 19.02%. With a current market capitalization of approximately $119.00 billion, KKR’s growth story is nothing short of...

Continue Reading